Patients who cannot have surgery for an early stage lung cancer may now benefit from a new radiation therapy technology called stereotactic...
Patients who cannot have surgery for an early stage lung cancer may now benefit from a new radiation therapy technology called stereotactic radiation therapy (STARS). This treatment can typically be given in 3 or 4 days as opposed to the 5 or 6 weeks with conventional radiation therapy. For patients who CAN have surgery, an operation that removes the lobe of the lung containing the cancer and lymph nodes is the current standard of care.
Because of the good results seen so far with stereotactic radiation therapy, it is now being considered as an alternative to surgery for patient who are fit enough to have surgery.
Jack Roth, M.D., in the thoracic surgery department at MD Anderson Cancer Center, discusses this clinical trial (STARS) that compares stereotactic radiation therapy with traditional surgery.